Related Experiment Videos
Myocardial revascularization in the patient with severe left ventricular dysfunction
Critical Care Nursing Clinics of North America
|December 1, 1993
Summary
Coronary artery bypass surgery is now safe for patients with poor ventricular function, offering better outcomes than medical management or heart transplantation. This advancement expands treatment options for complex cardiac conditions.
Area of Science:
- Cardiology
- Cardiac Surgery
- Medical Research
Background:
- Historically, impaired ventricular function was a contraindication for myocardial revascularization.
- Advancements in surgical techniques and patient management have evolved.
- Previously prohibitive surgical risks are now being managed effectively.
Purpose of the Study:
- To evaluate the safety and efficacy of myocardial revascularization in patients with poor ventricular function.
- To compare surgical outcomes with medical management and heart transplantation.
- To highlight the expanding indications for coronary artery bypass procedures.
Main Methods:
- Retrospective analysis of patients with reduced ejection fraction undergoing myocardial revascularization.
- Comparison of operative mortality and long-term survival rates.
- Assessment of functional status and quality of life post-surgery.
Main Results:
- Patients with poor ventricular function now undergo coronary artery bypass surgery with acceptable operative mortality.
- Long-term outcomes for these patients are successful and often superior to alternatives.
- Surgical revascularization demonstrates significant benefits over medical management.
Conclusions:
- Myocardial revascularization is a viable and effective treatment option for selected patients with poor ventricular function.
- Surgical intervention can lead to improved long-term results compared to non-surgical approaches.
- The paradigm for treating ischemic heart disease in patients with ventricular dysfunction has shifted favorably.